This compound is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of various active pharmaceutical ingredients (APIs). It plays a crucial role in the development of drugs targeting neurological disorders, particularly those involving the modulation of neurotransmitter systems. Its unique structure allows for the creation of molecules with enhanced binding affinity and selectivity, making it valuable in the design of treatments for conditions like depression, anxiety, and chronic pain. Additionally, it is explored in research for its potential applications in developing novel therapeutic agents with improved pharmacokinetic properties.